These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18247158)

  • 21. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis.
    Kappert K; Sparwel J; Sandin A; Seiler A; Siebolts U; Leppänen O; Rosenkranz S; Ostman A
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2644-51. PubMed ID: 16990553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway.
    Zhou CH; Wu XH; Wu YQ
    Eur J Pharmacol; 2009 Aug; 615(1-3):55-60. PubMed ID: 19486902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury.
    Malabanan KP; Kanellakis P; Bobik A; Khachigian LM
    Circ Res; 2008 Aug; 103(4):378-87. PubMed ID: 18617696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor.
    George J; Sack J; Barshack I; Keren P; Goldberg I; Haklai R; Elad-Sfadia G; Kloog Y; Keren G
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):363-8. PubMed ID: 14670932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: effects of altered intracellular Ca2+ regulation.
    Egan CG; Wainwright CL; Wadsworth RM; Nixon GF
    Cardiovasc Res; 2005 Aug; 67(2):308-16. PubMed ID: 15885673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo.
    Bond M; Wu YJ; Sala-Newby GB; Newby AC
    Cardiovasc Res; 2008 Nov; 80(2):290-8. PubMed ID: 18599477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of OD 78 [3-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl ester] on the proliferation and migration of TNF-α-induced rat aortic smooth muscle cells.
    Lim Y; Tudev M; Park ES; Kim WS; Lim IH; Lee MY; Lee H; Jung JK; Hong JT; Yoo HS; Lee MK; Pyo MY; Yun YP
    Arch Pharm Res; 2011 Jul; 34(7):1191-9. PubMed ID: 21811927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway.
    Yang YB; Yang YX; Su B; Tang YL; Zhu BY; Hu ZW; Li GY; Li YJ; Liao DF
    Eur J Pharmacol; 2007 Sep; 570(1-3):125-34. PubMed ID: 17628533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
    Kim HJ; Yoo EK; Kim JY; Choi YK; Lee HJ; Kim JK; Jeoung NH; Lee KU; Park IS; Min BH; Park KG; Lee CH; Aronow BJ; Sata M; Lee IK
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1558-64. PubMed ID: 19696405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model.
    Guan S; Tang Q; Liu W; Zhu R; Li B
    Drug Dev Res; 2014 Dec; 75(8):489-96. PubMed ID: 25452110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway.
    Sung JY; Choi HC
    Vascul Pharmacol; 2012; 56(1-2):1-8. PubMed ID: 21708289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury.
    Maffia P; Grassia G; Di Meglio P; Carnuccio R; Berrino L; Garside P; Ianaro A; Ialenti A
    Circulation; 2006 Aug; 114(5):430-7. PubMed ID: 16864728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of cyclooxygenase-2 by motorcycle exhaust particulate-induced reactive oxygen species enhances rat vascular smooth muscle cell proliferation.
    Tzeng HP; Yang RS; Ueng TH; Liu SH
    Chem Res Toxicol; 2007 Aug; 20(8):1170-6. PubMed ID: 17645304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF inhibits PDGF-stimulated calcium signaling independent of phospholipase C and protein kinase C.
    Chandra A; Angle N
    J Surg Res; 2006 Apr; 131(2):302-9. PubMed ID: 16054650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiating agent, hexamethylene bisacetamide, inhibits neointimal formation after vascular injury.
    Ishikawa S; Hori S; Kusuhara M; Kanai Y; Handa S; Yamaguchi K; Hosoda Y; Ogawa S
    Coron Artery Dis; 1997 Jan; 8(1):28-32. PubMed ID: 9101119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSC-36/FRP inhibits vascular smooth muscle cell proliferation and migration.
    Liu S; Wang L; Wang W; Lin J; Han J; Sun H; Guo H; Sun R; Wu Q
    Exp Mol Pathol; 2006 Apr; 80(2):132-40. PubMed ID: 16256108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular mechanism of actinomycin D in preventing neointimal formation in rat carotid arteries after balloon injury.
    Wu CH; Pan JS; Chang WC; Hung JS; Mao SJ
    J Biomed Sci; 2005; 12(3):503-12. PubMed ID: 15959627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
    Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
    Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration.
    Fu M; Zhang J; Tseng YH; Cui T; Zhu X; Xiao Y; Mou Y; De Leon H; Chang MM; Hamamori Y; Kahn CR; Chen YE
    Circulation; 2005 Mar; 111(8):1071-7. PubMed ID: 15710763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.